Related Experiment Video
Updated: Sep 14, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Subclinical Delayed Coronary Ostial Obstruction After Transcatheter Aortic Valve Replacement With a High-Frame
Paula Ackermann1, Mateo Marin-Cuartas1, A Luise Bayer2
1University Department of Cardiac Surgery, Heart Center Leipzig, Leipzig, Germany.
Insights
Delayed coronary obstruction can occur after transcatheter aortic valve replacement (TAVR). Endothelial growth around ACURATE neo valves caused this rare complication, emphasizing careful prosthesis selection.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Transcatheter aortic valve replacement (TAVR) is a common procedure for aortic stenosis.
- The ACURATE neo device is a widely used transcatheter heart valve (THV).
- Long-term complications of THV implantation require ongoing investigation.
Observation:
- Two patients experienced acute heart failure months after ACURATE neo THV implantation.
- Exploration revealed massive endothelial overgrowth around the THV, obscuring coronary ostia.
- This led to subclinical delayed coronary ostial obstruction.
Findings:
- Endothelial hyperplasia around the ACURATE neo THV can cause delayed coronary obstruction.
- This complication is rare but serious, particularly in patients with specific aortic anatomies.
- THV explantation and replacement were necessary to resolve the obstruction.
Implications:
- Highlights a rare but significant complication associated with the ACURATE neo THV.
- Underscores the critical importance of careful THV prosthesis selection for individual patient anatomy.
- Emphasizes the need for optimal implantation techniques to mitigate risks in patients with small aortic roots or low coronary ostia.
Abstract:
We herein describe 2 cases of subclinical delayed coronary obstruction following transcatheter aortic valve replacement. Two female patients (74 and 83 years of age) were admitted to our department with acute heart failure due to severe valvular dysfunction of the transcatheter heart valves (THVs), which had been implanted 38 and 24 months earlier (ACURATE neo). During THV explantation and surgical aortic valve replacement, a massive circumferential endothelial growth around the upper crown of the THV prostheses was observed, leading to sequestration of the sinus of Valsalva with subclinical delayed coronary ostial obstruction. These 2 cases demonstrate a rare but serious complication of the ACURATE neo THV, highlighting the importance of THV prosthesis selection and implantation technique. In the light of lifetime management for aortic stenosis and increasing use in younger and lower risk patients, optimal implantation technique and appropriate THV selection are crucial for patients with small aortic roots, narrow sinuses of Valsalva, and low coronary ostia.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

